An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment

Renal impairment (RI) is a relatively common complication of multiple myeloma, which increases in frequency as disease becomes more advanced and recovery of renal function becomes less likely as patients progress through lines of therapy. Clinical trials in the relapsed/refractory multiple myeloma (...

Descripción completa

Detalles Bibliográficos
Autores principales: Dimopoulos, Meletios A., Mikhael, Joseph, Terpos, Evangelos, Leleu, Xavier, Moreau, Philippe, Bladé, Joan, Kim, Jin Seok, Stockerl-Goldstein, Keith, Richardson, Paul G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980434/
https://www.ncbi.nlm.nih.gov/pubmed/35392438
http://dx.doi.org/10.1177/20406207221088458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980434/
https://www.ncbi.nlm.nih.gov/pubmed/35392438
http://dx.doi.org/10.1177/20406207221088458

Ejemplares similares